NCT03071952

Brief Summary

The primary objective of this study is to assess the clinical efficacy of AAIR (Atrial-paced Atrial-sensed Inhibitory Rate-Modulated) pacing treatment for heart failure (HF) patients with chronotropic incompetence (CI) in terms of exercise tolerance and quality of life. Specifically, the study will assess the changes in cardiac function associated with changes of physical exercise intensity and heart rate in AAIR pacing mode compared with AAI pacing mode.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
11

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 8, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

October 9, 2016

Completed
5 months until next milestone

First Posted

Study publicly available on registry

March 7, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 24, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 24, 2017

Completed
Last Updated

January 11, 2018

Status Verified

January 1, 2018

Enrollment Period

1.1 years

First QC Date

September 8, 2016

Last Update Submit

January 9, 2018

Conditions

Keywords

Heart FailureChronotropic IncompetenceRate ResponseExercise Test

Outcome Measures

Primary Outcomes (1)

  • The treadmill walk duration change

    The treadmill walk duration change from 3-6 months to 6-12 months post pacemaker implantation

Secondary Outcomes (1)

  • The 6 minutes hall walk distance change

    3-6 months and 6-12 months post pacemaker implantation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

In the study, total 30 heart failure patients with chronotropic incompetence who meet the inclusion and exclusion criteria would be enrolled from the ourtpatients in Fuwai Hospital.

You may qualify if:

  • Patient is willing to give informed consent.
  • Patient is between 18 and 70 years of age (including 18 and 70 years of age).
  • Patients can perform treadmill exercise test for at least 8 minutes.
  • Patient has been diagnosed with stable chronic HF according to HF guidance, including HFpEF (Heart Failure with preserved Ejection Fraction) and HFrEF (Heart Failure with reduced Ejection Fraction) patients.
  • NYHA class I- III, with left ventricular ejection fraction less than 55% and more than 25%.
  • Heart rate during treadmill test cannot reach 70% APMHR (Age Predicted Maximal Heart Rate) in (diagnostic criteria for CI, in accordance with class IA indications of pacing therapy for CI).

You may not qualify if:

  • Patient with severe liver or kidney dysfunction.
  • Patient has contraindications for pacing therapy.
  • Patient has CI and is under appropriate clinical therapy.
  • Patient has persistent or permanent atrial fibrillation (AF).
  • Patient whose heart rate baseline at resting state is greater than 95 beats per minutes (BPM).
  • Patient has contraindications for cardio-pulmonary exercise testing, including but not limited to unstable angina, decompensated heart failure, active pericarditis or myocarditis, hypertrophic cardiomyopathy, valvular heart disease and ECG ST-segment shift \> 2mm at resting state.
  • Less than 6 months after angina and ST dynamic changes during last 3 months.
  • Patient with class I (with PR interval more than 200ms), II or III atrioventricular block, or interventricular block.
  • NYHA Class IV.
  • Less than 45 days after myocardial infarction.
  • Less than 3 months after acute heart failure.
  • Patient has uncontrolled hypertension.
  • Patient is unwilling to sign the patient informed consent.
  • Patient is pregnant or has pregnancy intention in the study duration.
  • Patient has a medical condition that would limit study participation.
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fuwai Hospital

Beijing, Beijing Municipality, 100037, China

Location

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Shu Zhang, PhD

    Chinese Academy of Medical Sciences, Fuwai Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 8, 2016

First Posted

March 7, 2017

Study Start

October 9, 2016

Primary Completion

November 24, 2017

Study Completion

November 24, 2017

Last Updated

January 11, 2018

Record last verified: 2018-01

Data Sharing

IPD Sharing
Will not share

Locations